3 wins for Regeneron: Phase 3 trial success vs allergies
Regeneron’s itepekimab antibody treatment posts 3 wins in Phase 3 trials, showing significant improvement against both cat allergies and seasonal pollen allergies.
pollen allergy
Read More
ph. 3 win: Regeneron’s 2 Allergy Antibodies Succeed
Regeneron announces a major ph. 3 win for its new antibody treatment, showing significant success in reducing symptoms for both cat and seasonal pollen allergies.